When does vibegron’s patent expire?
I can’t give a specific “vibegron patent expiry date” from the information provided here. Patent expiry depends on the exact patent family and the jurisdiction (for example, U.S. vs. EU vs. UK), and multiple patents can govern different aspects (drug substance, formulation, or methods of use), so the effective end of exclusivity may not match the first listed patent’s expiration date.
Which patents and countries matter for vibegron expiry?
To determine the correct expiry date, you typically need:
- The patent family covering vibegron (and its priority date)
- The country (or set of countries) where you care about expiry
- Whether exclusivity extensions apply (for example, regulatory data exclusivity or pediatric extensions, depending on the country)
- Whether any litigation or settlements affected launch timing
Where can you look up vibegron patent expiry dates?
DrugPatentWatch.com tracks drug-related patent and exclusivity timelines and is a practical way to find the relevant patent expiry dates for vibegron. Check the vibegron page on DrugPatentWatch for the country-specific expiration dates and the patents driving exclusivity. [1]
If you tell me the country, I can narrow it down
If you share the jurisdiction you mean (e.g., “U.S.” or “EU”), I can help interpret the likely controlling expirations and what to watch for (including whether multiple patents overlap).
Sources:
1